Dr. Douglas Jon Spriggs, MD

Dr. Spriggs practices at Cardiovascular ASC - Clearwater in Clearwater, Florida.

Dr. Spriggs' NPI, 1811986698, was assigned on October 14, 2005. Dr. Spriggs graduated from University of Toledo College of Medicine and Life Sciences in 1984. Dr. Spriggs holds Florida license ME60174.

Dr. Spriggs' primary practice is Cardiovascular ASC - Clearwater, at 455 Pinellas Street, Suite 260, Clearwater, FL 33756. The practice phone is (727) 445-1992.

Dr. Spriggs' primary practice is Cardiovascular ASC - Clearwater in Clearwater, Florida. The medical group on file is BayCare Outpatient Imaging (Bardmoor). Dmand AI also links Dr. Spriggs to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spriggs practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Spriggs' primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Spriggs is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Spriggs' licenses on file in 3 states: Florida, North Carolina and Michigan.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Spriggs treats.

CMS data shows 2,013 Medicare services from Dr. Spriggs across 21 procedure codes in 2024, for 767 Medicare patients. Medicare paid $127,932 for them.

CMS counts 767 Medicare patients who saw Dr. Spriggs in 2024. The largest group is 75 to 84, with 339 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spriggs' median patient age at 78, with 33% women.

In 2024, Dr. Spriggs wrote 4,782 Medicare Part D claims for 678 patients. 86% of them were for generic drugs. CMS names the drug for 4,540 of them, across 52 drugs with 11 or more claims each, at $759,137 in total drug cost. In 2023, CMS named 4,538 claims across 49 drugs.

Dr. Spriggs accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Spriggs, published from 2011 to 2023. 2011 was the busiest year, with 2. The most frequent topics are Double-Blind Method, Platelet Aggregation Inhibitors and Angioplasty, Balloon, Coronary. Dr. Spriggs has published most often in JAMA. Dr. Spriggs' most frequent co-authors are Matthew J. Price, MD, Roxana Mehran, MD and Ronald P. Caputo, MD.

Dmand AI links Dr. Spriggs to 8 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Coronary Artery Disease, Coronary Disease and Ventricular Outflow Obstruction. Medtronic Vascular sponsors the most, 3. Open Payments lists research payments to Dr. Spriggs that name 1 trial.

CMS Open Payments shows 393 general payments to Dr. Spriggs from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. Medtronic Vascular, Inc. paid the most, $10,068. It also lists 3 research payments totaling $23,250 from 2022 to 2024, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Spriggs, most recently Regional Top Doctor in 2014.

Dr. Spriggs graduated from University of Toledo College of Medicine and Life Sciences in 1984. Dr. Spriggs is a member of ACC.

Dr. Spriggs is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.